SLT – Mechanism of Action

Description:

Brian Francis, MD – from the University of Southern California of Los Angeles and the Doheny Eye Institute was one of the early adopters of the  Selective Laser Trabeculoplasty (SLT) technology – a micro-incisional glaucoma surgical procedure.

Publish Date:

January 29, 2017

Speaker:

Brian Francis, MD

Ophthalmology
Devices

Learn more about our innovative Vision solutions

Digital Duet Device

Digital Duet

The first and only all-in-one digital platform for Glaucoma and PCO therapies
Digital Trio Device

Digital Trio

3 in 1 digital platform for Glaucoma and Retina care
Optilight Device

OptiLight

A bright solution for dry eyes
Array LaserLink Device

ArrayTM LaserLinkTM

Pattern Scanning Laser Technology
Vision One Device

Vision One

Modular Multi-Wave Photocoagulator
Selecta Duet Device

Selecta Duet

SLT Technology and a Yag Photodisruptor in One Platform
Selecta Trio Device

Selecta Trio

Retinal, Cataract and Glaucoma Therapy in One Platform
Novus Spectra Device

Novus SpectraTM

High-Powered Photocoagulator
LumeProbe

LumeProbeTM

Endo-Photocoagulation Laser Probes

Explore Other Resources

Dry EyePress PublicationsTopicTreatment TypeVision Resource Hub
Dry EyePress PublicationsTopicTreatment TypeVision Resource Hub

The 2024 IPL Report

READ MORE

    PB-1005974 rev B